JP2016520573A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520573A5
JP2016520573A5 JP2016510807A JP2016510807A JP2016520573A5 JP 2016520573 A5 JP2016520573 A5 JP 2016520573A5 JP 2016510807 A JP2016510807 A JP 2016510807A JP 2016510807 A JP2016510807 A JP 2016510807A JP 2016520573 A5 JP2016520573 A5 JP 2016520573A5
Authority
JP
Japan
Prior art keywords
composition
angiotensin
patient
composition according
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016510807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520573A (ja
JP6522584B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/035511 external-priority patent/WO2014176534A1/en
Publication of JP2016520573A publication Critical patent/JP2016520573A/ja
Publication of JP2016520573A5 publication Critical patent/JP2016520573A5/ja
Priority to JP2019000124A priority Critical patent/JP6962943B2/ja
Application granted granted Critical
Publication of JP6522584B2 publication Critical patent/JP6522584B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016510807A 2013-04-26 2014-04-25 腎不全を処置するための組成物及び方法 Active JP6522584B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019000124A JP6962943B2 (ja) 2013-04-26 2019-01-04 腎不全を処置するための組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361816578P 2013-04-26 2013-04-26
US61/816,578 2013-04-26
PCT/US2014/035511 WO2014176534A1 (en) 2013-04-26 2014-04-25 Compositions and methods for treating renal failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019000124A Division JP6962943B2 (ja) 2013-04-26 2019-01-04 腎不全を処置するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2016520573A JP2016520573A (ja) 2016-07-14
JP2016520573A5 true JP2016520573A5 (https=) 2017-06-08
JP6522584B2 JP6522584B2 (ja) 2019-05-29

Family

ID=51792411

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016510807A Active JP6522584B2 (ja) 2013-04-26 2014-04-25 腎不全を処置するための組成物及び方法
JP2019000124A Active JP6962943B2 (ja) 2013-04-26 2019-01-04 腎不全を処置するための組成物及び方法
JP2021168488A Pending JP2022009125A (ja) 2013-04-26 2021-10-14 腎不全を処置するための組成物及び方法
JP2023177200A Pending JP2024009958A (ja) 2013-04-26 2023-10-13 腎不全を処置するための組成物及び方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019000124A Active JP6962943B2 (ja) 2013-04-26 2019-01-04 腎不全を処置するための組成物及び方法
JP2021168488A Pending JP2022009125A (ja) 2013-04-26 2021-10-14 腎不全を処置するための組成物及び方法
JP2023177200A Pending JP2024009958A (ja) 2013-04-26 2023-10-13 腎不全を処置するための組成物及び方法

Country Status (6)

Country Link
US (3) US9457059B2 (https=)
EP (2) EP2988770A4 (https=)
JP (4) JP6522584B2 (https=)
CN (1) CN105592855A (https=)
AU (4) AU2014256944B2 (https=)
WO (1) WO2014176534A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
CN105592855A (zh) * 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法
RS59804B1 (sr) 2013-12-18 2020-02-28 The George Washington University A Congressionally Chartered Not For Profit Corporation Angiotenzin ii u kombinaciji za lečenje hipotenzije
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) * 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
JP2017014206A (ja) * 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド 腹水の治療
EP3400000B1 (en) 2016-01-07 2023-12-06 La Jolla Pharma, LLC Methods for administering angiotensin ii
EP3235496A1 (en) * 2016-04-19 2017-10-25 Noorik Biopharmaceuticals AG Treatment of acute renal failure
JP7057365B2 (ja) 2016-09-30 2022-04-19 ゼナメッド コーポレーション ミドドリンの組成物およびその使用方法
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
JP7364568B2 (ja) 2017-12-22 2023-10-18 ゼナメッド コーポレーション 持続放出ミドドリン塩酸塩組成物及び使用方法
JP7523775B2 (ja) * 2018-06-15 2024-07-29 フェリング ベスローテン フェンノートシャップ テルリプレシン組成物及びその使用
TW202031283A (zh) 2018-09-20 2020-09-01 馬克 Ｃ 曼寧 穩定卡貝縮宮素鼻內製劑
EP3852724A4 (en) 2018-09-20 2022-07-06 Levo Therapeutics, Inc. CARBETOCIN DRUG PRODUCT AND PROCESS FOR ITS MANUFACTURE
KR20220011697A (ko) 2019-05-22 2022-01-28 바이오비에 아이앤씨. 테를리프레신 제형
JP7694404B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機
JP7694406B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機
JP7694400B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機
JP7694403B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機
JP7694407B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機
JP7694405B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機
JP7694401B2 (ja) * 2022-01-25 2025-06-18 株式会社三洋物産 遊技機

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
US6592865B2 (en) 2001-06-04 2003-07-15 Human Genome Sciences, Inc. Methods and compositions for modulating ACE-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) * 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
CN101795675A (zh) * 2006-11-17 2010-08-04 达沃尔泰拉公司 使用具有Eudragit包衣的Zn/果胶珠粒进行的结肠递送
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
WO2012009545A1 (en) * 2010-07-14 2012-01-19 Cumberland Emerging Technologies, Inc Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-a2 receptor antagonists
CN105592855A (zh) * 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法

Similar Documents

Publication Publication Date Title
JP2016520573A5 (https=)
JP7421520B2 (ja) Ｔｐｐ１配合物及びｃｌｎ２疾患を治療するための方法
JP2022009125A5 (https=)
Ochala et al. Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms
JP2021167314A (ja) Ｇｉｐ／ｇｌｐ１アゴニスト組成物
JP2016539921A5 (https=)
MX2012012051A (es) Compuesto organico para usarse en el tratamiento de cancer de higado.
JP2014528901A5 (https=)
JP7594045B2 (ja) 薬学的組成物
NZ598534A (en) Dosage regimen of an s1p receptor modulator
JP2016516074A5 (https=)
JP2019504012A5 (https=)
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
RU2015116264A (ru) Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
JP2017519799A5 (https=)
JP2012502103A5 (https=)
JP2011513310A5 (https=)
NZ754328A (en) Marker for acid sphingomyelinase disorders and uses thereof
JP2012525391A5 (https=)
WO2012044783A3 (en) Method of achieving a thymosin beta 4 concentration in a human patient
RU2013112890A (ru) Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
Allen et al. Acid aspiration-induced airways hyperresponsiveness in mice
RU2014126070A (ru) Способы лечения и предотвращения глазных заболеваний
JP2019535830A5 (https=)
HK1209041A1 (en) A method of weight reduction